Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 1
1954 3
1955 1
1980 1
1981 2
1985 1
1987 1
1990 3
1992 3
1993 5
1994 6
1995 3
1996 3
1997 7
1998 4
1999 7
2001 1
2003 6
2004 2
2005 3
2006 6
2007 2
2008 2
2009 2
2010 1
2011 3
2012 6
2013 7
2014 21
2015 11
2016 8
2017 12
2018 13
2019 11
2020 16
2021 14
2022 14
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: sacco c. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
Ophthalmic complications of Lemierre syndrome.
Kreuzpointner R, Valerio L, Corsi G, Zane F, Sacco C, Holm K, Righini C, Pecci A, Zweifel S, Barco S. Kreuzpointner R, et al. Among authors: sacco c. Acta Ophthalmol. 2022 Feb;100(1):e314-e320. doi: 10.1111/aos.14871. Epub 2021 Apr 8. Acta Ophthalmol. 2022. PMID: 33829646 Free article.
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.
Mateo-Urdiales A, Sacco C, Petrone D, Bella A, Riccardo F, Del Manso M, Bressi M, Siddu A, Brusaferro S, Palamara AT, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Mateo-Urdiales A, et al. Among authors: sacco c. JAMA Netw Open. 2023 Oct 2;6(10):e2336854. doi: 10.1001/jamanetworkopen.2023.36854. JAMA Netw Open. 2023. PMID: 37792377 Free PMC article.
Lifelong vaccination as a key disease-prevention strategy.
Bonanni P, Sacco C, Donato R, Capei R. Bonanni P, et al. Among authors: sacco c. Clin Microbiol Infect. 2014 May;20 Suppl 5:32-6. doi: 10.1111/1469-0691.12537. Epub 2014 Jan 19. Clin Microbiol Infect. 2014. PMID: 24829938 Free article. Review.
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023.
Fabiani M, Mateo-Urdiales A, Sacco C, Rota MC, Fotakis EA, Petrone D, Del Manso M, Siddu A, Stefanelli P, Bella A, Riccardo F, Rezza G, Palamara AT, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: sacco c. Euro Surveill. 2023 Aug;28(32):2300397. doi: 10.2807/1560-7917.ES.2023.28.32.2300397. Euro Surveill. 2023. PMID: 37561053 Free PMC article.
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022.
Fabiani M, Mateo-Urdiales A, Sacco C, Fotakis EA, Rota MC, Petrone D, Bressi M, Del Manso M, Siddu A, Fedele G, Stefanelli P, Bella A, Riccardo F, Palamara AT, Rezza G, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: sacco c. Euro Surveill. 2023 Feb;28(8):2300105. doi: 10.2807/1560-7917.ES.2023.28.8.2300105. Euro Surveill. 2023. PMID: 36820640 Free PMC article.
Cisplatin and gemcitabine in non-small-cell lung cancer.
Cartei G, Sacco C, Sibau A, Pella N, Iop A, Tabaro G. Cartei G, et al. Among authors: sacco c. Ann Oncol. 1999;10 Suppl 5:S57-62. doi: 10.1093/annonc/10.suppl_5.s57. Ann Oncol. 1999. PMID: 10582141 Free article. Review.
201 results